Since 1996 WHN is the second oldest medical website on the net, second only to the American Medical Association, servicing over 35,000 physicians and scientists worldwide.

Non-Profit Trusted Source of Non-Commercial Health Information

WHN Forum background globe
AI Assistant
Forums
Forum
General Discussion,...
Anti-Aging Enzyme C...
 
Notifications
Clear all

Anti-Aging Enzyme Class Revealed by New TOR Inhibitor

 
General Discussion, Q&A
Last Post by Anonymous 8 months ago
1 Posts
1 Users
0 Reactions
135 Views
Solved
RSS
Posts: 1
 Dr. Young
Topic starter
Translate ▼
English
Spanish
French
German
Italian
Portuguese
Russian
Chinese
Japanese
Korean
Arabic
Hindi
Dutch
Polish
Turkish
Vietnamese
Thai
Swedish
Danish
Finnish
Norwegian
Czech
Hungarian
Romanian
Greek
Hebrew
Indonesian
Malay
Ukrainian
Bulgarian
Croatian
Slovak
Slovenian
Serbian
Lithuanian
Latvian
Estonian
Sep 30, 2025 7:44 pm
(@Dr. Young)
Joined: 8 months ago

Researchers at Queen Mary University of London’s School of Biological and Behavioural Sciences, using the simple fission yeast as a model, have shown that a new target of rapamycin (TOR) inhibitor, rapalink-1, which is in development against cancer, prolongs chronological lifespan.

The study, headed by Charalampos Rallis, PhD, revealed TOR-regulated genes with unknown roles in aging, and could shed new light on how drugs and natural metabolites can influence lifespan through the TOR pathway.

https://www.genengnews.com/topics/translational-medicine/anti-aging-enzyme-class-revealed-by-new-tor-inhibitor/


Topic Tags
anti-aging tor inhibitor rapalink-1 agmatinases lifespan

Leave a reply

Author Name

Author Email

Title *

Maximum allowed file size is 400MB

 
Preview 0 Revisions Saved
Forum Jump:
  Previous Topic
Next Topic  
Related Topics
Topic Tags:  anti-aging (49) , tor inhibitor (1) , rapalink-1 (1) , agmatinases (1) , lifespan (17) ,